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Idiopathic congenital nystagmus is characterized by
involuntary, periodic, predominantly horizontal oscillations
of both eyes. We identified 22 mutations in FRMD7 in
26 families with X-linked idiopathic congenital nystagmus.
Screening of 42 singleton cases of idiopathic congenital
nystagmus (28 male, 14 females) yielded three mutations (7%).
We found restricted expression of FRMD7 in human embryonic
brain and developing neural retina, suggesting a specific role in
the control of eye movement and gaze stability.
The prevalence of idiopathic congenital nystagmus (ICN) is estimated
to be 1 in 1,000. In ICN, visual function can be significantly reduced
owing to constant eye movement, but the degree of visual impairment
varies1,2. The disease is likely to be due to abnormal development of
areas in the brain controlling eye movements and gaze stability3. ICN
is distinct from other hereditary causes of nystagmus and ocular
pathology, including ocular albinism, congenital stationary night
blindness, achromatopsia, blue cone monochromatism and sensory
visual defects of early childhood such as congenital cataract, retinitis
pigmentosa, cone-rod dystrophy and optic nerve hypoplasia4.
ICN is usually inherited as an X-linked trait with incomplete
penetrance in females. Most families map to Xq26–q27 and the
locus (known as NYS1) has previously been mapped to a B12-Mb
interval between markers DXS9909 and DXS1211 (refs. 5,6). Others
have proposed a further reduction of the candidate region to an
interval between DXS8033 and DXS8043 based on a recombination
event in a clinically unaffected female7. X-linked genetic heterogeneity
has been suggested on the basis of a single ICN family that is reported
to map to Xp11.4– Xp11.3 (ref. 8).
We screened 16 families with X-linked ICN using 17 markers
extending from Xq26–Xq27 (Supplementary Fig. 1 online)6. In
these families, the disease was fully penetrant in males and B50%
penetrant in females. The phenotype was variable even within families
(Supplementary Fig. 2 and Supplementary Videos 1, 2 and 3 online).
In all 16 families, marker haplotypes were compatible with linkage to
Xq26–q27 (Supplementary Methods online). Recombinant events in
affected males in family N1 refined the location of NYS1 to aB7.5-Mb
interval between markers DXS1047 and DXS1041 (Fig. 1a,b).
The candidate interval contained 480 genes. We performed high-
throughput DNA sequence analysis of all coding exons of all genes
within this interval9. DNA from one affected male individual from
each of the 16 linked families was screened for mutations.
We detected mutations in FRMD7 (FERM domain–containing 7,
previously known as LOC90167) at Xq26.2 in 15/16 of the linked
families after screening 440 genes by sequence analysis (Fig. 1c).
FRMD7 has 12 exons and encodes a previously unidentified member
of the protein 4.1 superfamily (RefSeq accession number
NM_194277). All mutations identified in FRMD7 cosegregated with
disease in the linked families and were absent from 300 male control
chromosomes (Table 1). The nonsense mutations leading to Q201X
and R335X predict truncated proteins containing 28% and 47% of the
protein, respectively. Four of the five splice site mutations were at
conserved splice donor residues (position +1 and +2) and are
thus predicted to be pathological by classical exon skipping and
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nonsense-mediated decay. In family N7, whose members had the
mutation IVS2 +5G-A, we detected negligible amounts of transcript
in the proband by amplification of exons 1–5 in lymphocytes
compared with quantities in controls, suggesting that this is also
disease associated (Supplementary Fig. 3, Supplementary Methods
and Supplementary Table 1 online). The silent variant, G252A (V84V
in family N5), created a new splice acceptor site within exon 4 that
resulted in the loss of transcript containing the sequence of exons 1–5
and the rare presence of a transcript with exon 4 skipped in
lymphocytes (Supplementary Fig. 3).
The six missense mutations resulting in amino acid substitutions at
positions 24, 142, 231, 266, 271 and 301 in the linked families not only
involve highly conserved residues that are invariant in Rattus norve-
gicus, Mus musculus, Gallus gallus and Xenopus tropicalis but are also
located within invariant blocks of highly conserved residues, suggest-
ing that mutations at these locations are critical to the normal
function of the protein. Residues at position 142, 231, 271 and 301
are further conserved in Tetraodon nigroviridis. Furthermore, with the
exception of L231V, the mutations lead to changes in amino acids that
are largely nonconservative in function (G24R, L142R, A266P, C271Y
and Y301C). We modeled the effects of these mutations on the three-
dimensional structure of the protein by mapping them onto the
closest ortholog of known structure: the core domain of the cytoske-
letal protein 4.1R (1GG3 http://www.pdb.org/pdb/navbarsearch.
do?¼All&inputQuickSearch¼1gg3 in the Protein Data Bank)10,11.
The crystal structure extends from residues 1–279, and therefore we
were able to map all the changes in amino acids resulting from
missense mutations in FRMD7 except the
one leading to Y301C in the linked families.
We inspected the structural environment of
the disease-associated missense mutations
using the program Coot, which allows the
identity and conformation of residues to be
manipulated easily12. Although the effect on
the structure of L231V is not clearly apparent,
mutations leading to G24R, L142R and C271
are likely to destabilize the protein by the
introduction of larger amino acids within
restricted areas of the protein, and the intro-
duction of a proline residue at position 266
(A266P) will disrupt a helical domain in the
wild-type structure.
From the results above, we concluded that
mutations in FRMD7 are a major cause of
familial X-linked congenital motor nystag-
mus. We then assessed the prevalence of
mutations in FRMD7 in smaller families in
which linkage data was not available and in a
cohort of males and females with ICN but
without a family history of the condition. We
screened 14 families with two or more
affected individuals of either sex and found
mutations in 8/14 (57%). We also identified
mutations in 3/42 (7%) individuals without a
family history who had undergone careful
clinical and electrophysiological investigation
to exclude other causes of inherited congeni-
tal nystagmus (Table 1). We identified muta-
tions in 1/14 female singletons and 2/28 male
singletons, and none of the new mutations
was found in samples from 300 male control
individuals. The results suggest that mutation analysis of FRMD7 may
be considered of diagnostic value even in isolated cases of either sex.
Expression analysis of FRMD7 shows that the mRNA is present in
most tissues at low levels (http://symatlas.gnf.org/SymAtlas/). We
confirmed this by RT-PCR, detecting expression in human adult
kidney, liver, pancreas and, at low levels, heart and brain (data not
shown). Using this method in human fetal tissue, we detected the
transcript only in kidney.
We then performed in situ hybridization experiments in human
embryonic brain to investigate whether expression of FRMD7 was
localized or restricted. In embryos B56 d post-ovulation (d.p.o.),
there is expression in the ventricular layer of the forebrain, midbrain,
cerebellar primordium, spinal cord and the developing neural retina.
In earlier embryos (B37 d.p.o.) the expression is restricted to the
mid- and hindbrain, regions known to be involved in motor control of
eye movement (Fig. 1d–h).
The functional role of FRMD7 protein is unknown, but we detected
close amino acid sequence homology to FARP1 (FERM, RhoGEF and
pleckstrin domain protein 1; chondrocyte-derived ezrin-like protein;
NM_005766) and FARP2 (NM_014808) by BLAST search analysis
(http://www.ncbi.nlm.nih.gov/). The homology is concentrated at the
N terminus of the protein, where B41 and FERM-C domains are
present. The B41 domain is located at residues 1–192, and the FERM-
C domain is located at residues 186–279 in FRMD7. The location of
mutations relative to these domains is shown in Supplementary
Figure 3. The homologous protein FARP2 modulates the length and
the degree of branching of neurites in rat embryonic cortical neurons
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Figure 1 Refinement of the linkage interval to Xq26 and the pattern of expression of FRMD7 in brain
of human embryos B56 d.p.o. by in situ hybridization. (a) Pedigree of family N1. Arrow marks critical
individuals whose haplotypes define the minimum critical linkage interval. (b) Allele size for marker
DXS1047 in individual IV9 is discordant compared with the other affected males, V2 and VI2, and the
allele size at markers DXS1041 and DXS8050 in individual VI2 is discordant compared with
individuals V2 and IV9. (c) Location of LOC90167 (FRMD7) relative to the linkage markers DXS8072
and DXS8071. (d–h) A 599-bp and a 681-bp probe from unique sequence in the 3¢ UTR of FRMD7
were used as probes for in situ hybridization. d and f show in situ hybridization results using sense
probes, and e and g use antisense probes in similar anatomical locations. d and e are sagittal sections
showing the lateral ventricle (v), cerebellar peduncle (cp) and developing neural retina (r). h is an
enlargement of e, illustrating the retina. f and g are transverse sections showing the spinal cord (s),
hypothalamus (h) and cerebellar peduncle (cp). Scale bars: e, 2,000 mm; g, 1,800 mm. The study was
approved by the University of Leicester Ethics Committee. Written informed consent was obtained from
all study participants.
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and reorganizes the cytoskeleton. Overexpression of FARP2 results in
increased numbers of lateral growth cones extending from neurites
and associated decrease in total length of the neurites per neuron13,14.
Whether the function of FRMD7 is similar to FARP2 in specialized
neuronal pathways governing integration and coordination of eye
movements remains to be proved. The hypothesis that null mutations
in FRMD7, as found in families with X-linked congenital motor
nystagmus, alter the neurite length and degree of branching of
neurons as they develop in the midbrain, cerebellum and retina is a
plausible explanation of how defects in the protein coded for by
FRMD7 causes disease.
Note: Supplementary information is available on the Nature Genetics website.
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Table 1 Mutations in FRMD7 and variations in FRMD7
Sample Class Mutation/variation Origin
N15 M G70A, G24R Ireland
N7 T IVS2+5G-A England
N4 T IVS3+2T-G England
N5 S G252A, V84V England
N1, F26 T IVS4+1G-A England, England
N16 M T425G, L142R Ireland
N13 T IVS7+1G-C Madagascar
N2 T C601T, Q201X Italy-Germany
N3 M T691G, L231V Ireland-Germany
N6, SF21 M G796C, A266P England, England
N11 M G812A, C271Y Scotland
N14 T 887delG, G296fs Austria
N12 M A902G, Y301C England
N10, F24, SM08 T C1003T, R335X England, India, England
N9 T IVS11+1G-C Germany
F31 del 41_43delAGA, 14delI England
F21 M G71A, G24E Austria
F28 T 479insT, 160fs England
F15 M A661G, N221D England
F16 M G676A, A226T England
F20 M C1019T, S340L Romania
SM10 T 1262delC, 421fs England
Families where linkage was performed are prefixed by N; those that are familial but for
which no linkage data were available are prefixed F. Singleton males are prefixed by SM
and singleton females SF. The class of mutation is categorized as T (truncating),
M (missense), S (silent) and del (deletion). The country of origin is denoted. All
mutations identified were not found in 300 control male chromosomes. The reference
cDNA sequence NM_194277 is used as a basis for numbering the nucleotide of the
mutation. All mutations are located relative to the A of the first coding ATG at position
179. The reference protein sequence NP_919253 is used as the basis for numbering
the amino acid variation starting from the first methionine at position 1. The reference
sequence for the genomic sequence is AL49792.
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